These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27095416)

  • 1. Characterization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate Bayesian approach.
    Fu Z; Baker D; Cheng A; Leighton J; Appelbaum E; Aon J
    Biotechnol Prog; 2016 May; 32(3):799-812. PubMed ID: 27095416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a Saccharomyces cerevisiae fermentation process for production of a therapeutic recombinant protein using a multivariate Bayesian approach.
    Fu Z; Leighton J; Cheng A; Appelbaum E; Aon JC
    Biotechnol Prog; 2012 Jul; 28(4):1095-105. PubMed ID: 22581591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality by Design characterization of the perfusion culture process for recombinant FVIII.
    Kim YJ; Paik SH; Han SK; Lee S; Jeong Y; Kim JY; Kim CW
    Biologicals; 2019 May; 59():37-46. PubMed ID: 30926289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein.
    Looby M; Ibarra N; Pierce JJ; Buckley K; O'Donovan E; Heenan M; Moran E; Farid SS; Baganz F
    Biotechnol Prog; 2011; 27(6):1718-29. PubMed ID: 21948302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
    Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the quality by design approach to the drug substance manufacturing process of an Fc fusion protein: towards a global multi-step design space.
    Eon-duval A; Valax P; Solacroup T; Broly H; Gleixner R; Strat CL; Sutter J
    J Pharm Sci; 2012 Oct; 101(10):3604-18. PubMed ID: 22821774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality by design for herbal drugs: a feedforward control strategy and an approach to define the acceptable ranges of critical quality attributes.
    Yan B; Li Y; Guo Z; Qu H
    Phytochem Anal; 2014; 25(1):59-65. PubMed ID: 24108478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach.
    Liu H; Rivnay B; Avery K; Myung JH; Kozak D; Landrau N; Nivorozhkin A; Ashraf M; Yoon S
    Int J Pharm; 2020 Jul; 585():119473. PubMed ID: 32473373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate definition of control strategies using cross validated stepwise regression and Monte Carlo simulation.
    Yang PY; Hui CJ; Tien DJ; Snowden AW; Derfus GE; Opel CF
    J Biotechnol; 2019; 306S():100006. PubMed ID: 34112369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a monoclonal antibody cell culture production process using a quality by design approach.
    Horvath B; Mun M; Laird MW
    Mol Biotechnol; 2010 Jul; 45(3):203-6. PubMed ID: 20300882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Study of Intermediate and Critical Quality Attributes for Process Control of High-Shear Wet Granulation Using Multivariate Analysis and The Quality by Design Approach.
    Han JK; Shin BS; Choi DH
    Pharmaceutics; 2019 Jun; 11(6):. PubMed ID: 31159393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process characterization and Design Space definition.
    Hakemeyer C; McKnight N; St John R; Meier S; Trexler-Schmidt M; Kelley B; Zettl F; Puskeiler R; Kleinjans A; Lim F; Wurth C
    Biologicals; 2016 Sep; 44(5):306-18. PubMed ID: 27464992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products.
    Boussès C; Ferey L; Vedrines E; Gaudin K
    J Pharm Biomed Anal; 2015 Nov; 115():114-22. PubMed ID: 26183807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of experiments (DoE) in pharmaceutical development.
    N Politis S; Colombo P; Colombo G; M Rekkas D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):889-901. PubMed ID: 28166428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation.
    Aksu B; Paradkar A; de Matas M; Özer Ö; Güneri T; York P
    Pharm Dev Technol; 2013 Feb; 18(1):236-45. PubMed ID: 22881350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of critical quality attributes for monoclonal antibodies using quality by design principles.
    Alt N; Zhang TY; Motchnik P; Taticek R; Quarmby V; Schlothauer T; Beck H; Emrich T; Harris RJ
    Biologicals; 2016 Sep; 44(5):291-305. PubMed ID: 27461239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality attributes of recombinant therapeutic proteins: an assessment of impact on safety and efficacy as part of a quality by design development approach.
    Eon-Duval A; Broly H; Gleixner R
    Biotechnol Prog; 2012; 28(3):608-22. PubMed ID: 22473974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient high-throughput biological process characterization: Definitive screening design with the ambr250 bioreactor system.
    Tai M; Ly A; Leung I; Nayar G
    Biotechnol Prog; 2015; 31(5):1388-95. PubMed ID: 26138048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation process.
    Zhang J; Reddy J; Buckland B; Greasham R
    Biotechnol Bioeng; 2003 Jun; 82(6):640-52. PubMed ID: 12673763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding pharmaceutical quality by design.
    Yu LX; Amidon G; Khan MA; Hoag SW; Polli J; Raju GK; Woodcock J
    AAPS J; 2014 Jul; 16(4):771-83. PubMed ID: 24854893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.